PTEN alterations in sporadic and BRCA1-associated triple negative breast carcinomas
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PTEN alterations in sporadic and BRCA1-associated triple negative breast carcinomas
Authors
Keywords
Basal-like, Breast cancer, BRCA1, PTEN, Triple negative
Journal
Cancer Genetics
Volume 264-265, Issue -, Pages 8-15
Publisher
Elsevier BV
Online
2022-02-25
DOI
10.1016/j.cancergen.2022.02.008
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Population-Based Study of Genes Previously Implicated in Breast Cancer
- (2021) Chunling Hu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women
- (2021) et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer
- (2021) Andrew N.J. Tutt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Olaparib monotherapy as primary treatment in unselected triple negative breast cancer
- (2020) H.P. Eikesdal et al. ANNALS OF ONCOLOGY
- Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosis
- (2017) Shuting Li et al. Oncotarget
- Alterations of EGFR, p53 and PTEN that mimic changes found in basal-like breast cancer promote transformation of human mammary epithelial cells
- (2013) Maira M. Pires et al. CANCER BIOLOGY & THERAPY
- Comprehensive analysis of PTEN status in breast carcinomas
- (2013) Natalie Jones et al. INTERNATIONAL JOURNAL OF CANCER
- BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years
- (2012) L Robertson et al. BRITISH JOURNAL OF CANCER
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Evolutionary Pathways in BRCA1-Associated Breast Tumors
- (2012) Filipe C. Martins et al. Cancer Discovery
- Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer
- (2011) A. M. Gonzalez-Angulo et al. CLINICAL CANCER RESEARCH
- Molecular heterogeneity of triple-negative breast cancer and its clinical implications
- (2011) Sheeba Irshad et al. CURRENT OPINION IN ONCOLOGY
- CpG island hypermethylation ofBRCA1and loss of pRb as co-occurring events in basal/triple-negative breast cancer
- (2011) Olafur Andri Stefansson et al. Epigenetics
- Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer
- (2011) D. G. Evans et al. JOURNAL OF MEDICAL GENETICS
- Genomic signature of BRCA1 deficiency in sporadic basal-like breast tumors
- (2010) Simon A. Joosse et al. GENES CHROMOSOMES & CANCER
- Basal Cytokeratin and Epidermal Growth Factor Receptor Expression Are Not Predictive of BRCA1 Mutation Status in Women With Triple-negative Breast Cancers
- (2009) Laura C. Collins et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Synthetic lethal targeting ofPTENmutant cells with PARP inhibitors
- (2009) Ana M. Mendes-Pereira et al. EMBO Molecular Medicine
- Basal-Like Breast Cancer: A Critical Review
- (2008) Emad A. Rakha et al. JOURNAL OF CLINICAL ONCOLOGY
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now